|
9 Companies |
|
5 Products |
|
5 Products |
|
6 Mechanisms of Action |
|
0 Trials |
|
36 News |
|
- | Trial completion: Improving the Sleep and Circadian Rhythms of Mechanically Ventilated Patients (clinicaltrials.gov) - Feb 26, 2018
P=N/A, N=24, Completed, Sponsor: Brian Gehlbach
Active, not recruiting --> Completed
- | Trial completion: Sleep Wake and Melatonin Pattern in Craniopharyngioma (clinicaltrials.gov) - Feb 23, 2017
P=N/A, N=30, Completed, Sponsor: Rigshospitalet, Denmark
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | Phase classification, Enrollment change: Improving the Sleep and Circadian Rhythms of Mechanically Ventilated Patients (clinicaltrials.gov) - Feb 20, 2017
P=N/A, N=24, Active, not recruiting, Sponsor: Brian Gehlbach
Active, not recruiting --> Completed Phase classification: P1 --> P=N/A | N=58 --> 24
- Enrollment change, Trial termination, Trial primary completion date: SW: Cardiometabolic Risk of Shiftwork (clinicaltrials.gov) - Oct 3, 2016
P=N/A, N=64, Terminated, Sponsor: University of Chicago
Phase classification: P1 --> P=N/A | N=58 --> 24 N=90 --> 64 | Recruiting --> Terminated | Trial primary completion date: Jun 2014 --> Mar 2015; impossible to retain participants in 3-year longitudinal study
- Trial completion: SMART DOCS: Sustainable Methods, Algorithms, and Research Tools for Delivering Optimal Care Study (clinicaltrials.gov) - Jul 8, 2016
P=N/A, N=1836, Completed, Sponsor: Stanford University
N=90 --> 64 | Recruiting --> Terminated | Trial primary completion date: Jun 2014 --> Mar 2015; impossible to retain participants in 3-year longitudinal study Active, not recruiting --> Completed
- Trial primary completion date: Improving the Sleep and Circadian Rhythms of Mechanically Ventilated Patients (clinicaltrials.gov) - May 13, 2016
P1, N=58, Active, not recruiting, Sponsor: University of Iowa
Active, not recruiting --> Completed Trial primary completion date: Dec 2015 --> Dec 2016
- Trial completion, Enrollment change, Trial primary completion date: Sleep Disorders Management, Health and Safety in Police (clinicaltrials.gov) - Mar 19, 2016
P=N/A, N=731, Completed, Sponsor: Brigham and Women's Hospital
Trial primary completion date: Dec 2015 --> Dec 2016 Active, not recruiting --> Completed | N=2400 --> 731 | Trial primary completion date: Dec 2015 --> Sep 2010
- Enrollment change: Fire Fighter Fatigue Management Program: Operation Fight Fatigue (clinicaltrials.gov) - Mar 19, 2016
P=N/A, N=620, Completed, Sponsor: Brigham and Women's Hospital
Active, not recruiting --> Completed | N=2400 --> 731 | Trial primary completion date: Dec 2015 --> Sep 2010 N=6000 --> 620
- Enrollment closed, Enrollment change: SMART DOCS: Sustainable Methods, Algorithms, and Research Tools for Delivering Optimal Care Study (clinicaltrials.gov) - Mar 3, 2016
P=N/A, N=1836, Active, not recruiting, Sponsor: Stanford University
N=6000 --> 620 Recruiting --> Active, not recruiting | N=1506 --> 1836
- Trial completion, Trial primary completion date: Fire Fighter Fatigue Management Program: Operation Fight Fatigue (clinicaltrials.gov) - Aug 12, 2015
P=N/A, N=6000, Completed, Sponsor: Brigham and Women's Hospital
Recruiting --> Active, not recruiting | N=1506 --> 1836 Recruiting --> Completed | Trial primary completion date: Feb 2015 --> May 2014
- Trial completion, Enrollment change, Trial primary completion date: SID: Study of Sleep and Delirium in the Intensive Care Unit (ICU) (clinicaltrials.gov) - Jul 15, 2015
P=N/A, N=57, Completed, Sponsor: University of California, San Francisco
Recruiting --> Completed | Trial primary completion date: Feb 2015 --> May 2014 Recruiting --> Completed | N=100 --> 57 | Trial primary completion date: Dec 2014 --> Nov 2012
- ||||||| Hetlioz (tasimelteon) / Vanda
Trial completion: Tasimelteon for the Treatment of Non-24-hour Sleep-Wake Disorder (N24HSWD) in Blind Individuals With no Light Perception (clinicaltrials.gov) - Apr 21, 2015
P3, N=200, Completed, Sponsor: Vanda Pharmaceuticals
Recruiting --> Completed | N=100 --> 57 | Trial primary completion date: Dec 2014 --> Nov 2012 Recruiting --> Completed
- Trial completion: Fire Fighter Fatigue Management Program: Operation Healthy Sleep (clinicaltrials.gov) - Mar 20, 2015
P=N/A, N=7207, Completed, Sponsor: Brigham and Women's Hospital
Recruiting --> Completed Active, not recruiting --> Completed
- |||| Hetlioz (tasimelteon) / Vanda
Trial primary completion date: Tasimelteon for the Treatment of Non-24-hour Sleep-Wake Disorder (N24HSWD) in Blind Individuals With no Light Perception (clinicaltrials.gov) - Dec 10, 2014
P3, N=200, Recruiting, Sponsor: Vanda Pharmaceuticals
Active, not recruiting --> Completed Trial primary completion date: Sep 2014 --> Jan 2015
- Enrollment closed, Trial primary completion date: Improving the Sleep and Circadian Rhythms of Mechanically Ventilated Patients (clinicaltrials.gov) - Dec 10, 2014
P1, N=58, Active, not recruiting, Sponsor: University of Iowa
Trial primary completion date: Sep 2014 --> Jan 2015 Recruiting --> Active, not recruiting | Trial primary completion date: Mar 2012 --> Dec 2015
- ||||| Hetlioz (tasimelteon) / Vanda
Enrollment change: Efficacy and Safety of Tasimelteon Compared With Placebo in Totally Blind Subjects With Non-24-Hour Sleep-Wake Disorder (clinicaltrials.gov) - Oct 17, 2014
P3, N=136, Completed, Sponsor: Vanda Pharmaceuticals
Recruiting --> Active, not recruiting | Trial primary completion date: Mar 2012 --> Dec 2015 N=84 --> 136
- | Hetlioz (tasimelteon) / Vanda
Trial completion: Open Label Study to Assess the Absolute Bioavailability of Tasimelteon (HETLIOZ (clinicaltrials.gov) - Jul 30, 2014
P4, N=14, Completed, Sponsor: Vanda Pharmaceuticals
N=84 --> 136 Not yet recruiting --> Completed
- | New P2 trial: Evaluation of the Effects of Pharmaton Tablets on Mental Performance and Physical Fatigue in Nurses Working Night Shift (clinicaltrials.gov) - Jul 25, 2014
P2, N=32, Completed, Sponsor: Boehringer Ingelheim
- |||| Hetlioz (tasimelteon) / Vanda
Trial primary completion date: Tasimelteon for the Treatment of Non-24-hour Sleep-Wake Disorder (N24HSWD) in Blind Individuals With no Light Perception (clinicaltrials.gov) - May 27, 2014
P3, N=200, Recruiting, Sponsor: Vanda Pharmaceuticals
Not yet recruiting --> Completed Trial primary completion date: May 2014 --> Sep 2014
- | Hetlioz (tasimelteon) / Vanda
New P4 trial: Open Label Study to Assess the Absolute Bioavailability of Tasimelteon (HETLIOZ (clinicaltrials.gov) - May 4, 2014
P4, N=14, Not yet recruiting, Sponsor: Vanda Pharmaceuticals
- | Trial completion: Effects of Vitamin B12 on the Body's Internal Clock (clinicaltrials.gov) - Feb 22, 2014
P=N/A, N=10, Completed, Sponsor: Brigham and Women's Hospital
Trial primary completion date: May 2014 --> Sep 2014 Recruiting --> Completed
- ||||||| armodafinil / Generic mfg.
Trial completion: Armodafinil (CEP-10953) for Treatment of Narcolepsy, Obstructive Sleep Apnea/Hypopnea Syndrome, or Chronic Shift Work Sleep Disorder (clinicaltrials.gov) - Feb 22, 2014
P3, N=328, Completed, Sponsor: Cephalon
Recruiting --> Completed No longer recruiting --> Completed
- Enrollment open: SMART DOCS: Sustainable Methods, Algorithms, and Research Tools for Delivering Optimal Care Study (clinicaltrials.gov) - Jan 13, 2014
P=N/A, N=1506, Recruiting, Sponsor: Stanford University
No longer recruiting --> Completed Not yet recruiting --> Recruiting
- Enrollment open: Fire Fighter Fatigue Management Program: Operation Fight Fatigue (clinicaltrials.gov) - Aug 5, 2013
P=N/A, N=6000, Recruiting, Sponsor: Brigham and Women's Hospital
Not yet recruiting --> Recruiting Not yet recruiting --> Recruiting
- Enrollment change: Comprehensive Police Fatigue Management Program (clinicaltrials.gov) - Aug 5, 2013
P=N/A, N=683, Completed, Sponsor: Brigham and Women's Hospital
Not yet recruiting --> Recruiting N=3600 --> 683
- Enrollment closed: Sleep Disorders Management, Health and Safety in Police (clinicaltrials.gov) - Aug 5, 2013
P=N/A, N=2400, Active, not recruiting, Sponsor: Brigham and Women's Hospital
N=3600 --> 683 Recruiting --> Active, not recruiting
- Trial completion: Comprehensive Police Fatigue Management Program (clinicaltrials.gov) - Aug 5, 2013
P=N/A, N=683, Completed, Sponsor: Brigham and Women's Hospital
Recruiting --> Active, not recruiting Active, not recruiting --> Completed
- ||||||| Hetlioz (tasimelteon) / Vanda
Trial completion: Efficacy and Safety of Tasimelteon Compared With Placebo in Totally Blind Subjects With Non-24-Hour Sleep-Wake Disorder (clinicaltrials.gov) - May 19, 2013
P3, N=84, Completed, Sponsor: Vanda Pharmaceuticals
Active, not recruiting --> Completed Active, not recruiting --> Completed
- || Hetlioz (tasimelteon) / Vanda
Trial completion: Withdrawal Study to Demonstrate the Maintenance Effect in the Treatment of Non-24-Hour Sleep-Wake Disorder (clinicaltrials.gov) - May 19, 2013
P3, N=20, Completed, Sponsor: Vanda Pharmaceuticals
Active, not recruiting --> Completed Active, not recruiting --> Completed
- Trial completion: Does Cognitive Behaviour Therapy (CBT) Improve the Effect of Light Therapy (clinicaltrials.gov) - Apr 23, 2013
P=N/A, N=57, Completed, Sponsor: Uppsala University
Active, not recruiting --> Completed Active, not recruiting --> Completed
- Trial completion: Blue Wavelength Light-blocking Glasses in ADHD-Insomnia (clinicaltrials.gov) - Oct 15, 2012
P=N/A, N=22, Completed, Sponsor: University of Alabama at Birmingham
Active, not recruiting --> Completed Recruiting --> Completed
- Enrollment change: Randomized Controlled Trial on the Treatment Effects of Melatonin and Light Therapy on Delayed Sleep Phase Syndrome (clinicaltrials.gov) - Jun 7, 2012
P4, N=40, Completed, Sponsor: University of Bergen
Recruiting --> Completed N=60 --> 40
- Trial completion: Randomized Controlled Trial on the Treatment Effects of Melatonin and Light Therapy on Delayed Sleep Phase Syndrome (clinicaltrials.gov) - Jun 7, 2012
P4, N=40, Completed, Sponsor: University of Bergen
N=60 --> 40 Active, not recruiting --> Completed
- |||||| Hetlioz (tasimelteon) / Vanda
Enrollment open: Tasimelteon for the Treatment of Non-24-hour Sleep-Wake Disorder (N24HSWD) in Blind Individuals With no Light Perception (clinicaltrials.gov) - Oct 13, 2011
P3, N=200, Recruiting, Sponsor: Vanda Pharmaceuticals
Active, not recruiting --> Completed Not yet recruiting --> Recruiting
- ||| Hetlioz (tasimelteon) / Vanda
New P3 trial: Withdrawal Study to Demonstrate the Maintenance Effect in the Treatment of Non-24-Hour Sleep-Wake Disorder (clinicaltrials.gov) - Sep 6, 2011
P3, N=20, Completed, Sponsor: Vanda Pharmaceuticals
- |||||||||| Hetlioz (tasimelteon) / Vanda
New P3 trial: Tasimelteon for the Treatment of Non-24-hour Sleep-Wake Disorder (N24HSWD) in Blind Individuals With no Light Perception (clinicaltrials.gov) - Sep 1, 2011
P3, N=200, Recruiting, Sponsor: Vanda Pharmaceuticals